Introduction
The Bcl-2 family proteins are arguably the most proximal and important controls over apoptosis (Gross et al., 1999) . Some family members, like Bcl-2 and Bclx L , are anti-apoptotic, while others, like Bax and Bad, promote apoptosis. A primary focus of action of Bcl-2 family proteins is the mitochondrion, and depending upon the initiating agent, dierent members are involved in the regulatory process through the formation of homo-and hetero-dimers (Gross et al., 1999) .
Photodynamic therapy (PDT), a novel treatment for cancer (and other types of abnormal tissue), works through photoactivation of a tumor-localized photosensitive drug and generation of singlet oxygen and other reactive-oxygen species to kill cells and ablate tumors (Henderson and Dougherty, 1992; Moan and Berg, 1992) . Many of the most prominent photosensitizers in clinical and pre-clinical use localize preferentially in mitochondria of cultured cells, although the sites of subcellular localization in vivo are still not known Oleinick and Evans, 1998; Trivedi et al., 2000) . PDT with mitochondriallybound photosensitizers, such as the phthalocyanine Pc 4, is a strong inducer of apoptosis in both cultured cells and tumors (Agarwal et al., 1991; Colussi et al., 1999; Kessel and Luo, 1999; Oleinick and Evans, 1998) . A role for Bcl-2 in suppressing PDT-induced apoptosis was ®rst shown by He et al. (1996) . CHO cells overexpressing human Bcl-2 (line 5A100-Bcl2) were found to be more resistant to apoptosis caused by Pc 4-sensitized PDT than were the companion cells transfected with the neo gene (line 5A100). The Bcl-2-overexpressing cells were also partially resistant to killing by Pc 4-PDT, as determined by a clonogenic assay, with a dose-modifying factor of *2. These observations suggested that Bcl-2 protected the cells from sustaining lethal damage and was not merely delaying the progress of apoptosis or changing the mode by which a lethally damaged cell died. Granville et al. (1999) subsequently con®rmed the ability of overexpressed Bcl-2 to suppress PDT-induced apoptosis, using HL60 cells treated with benzoporphyrin derivative and light, and extended the observation to overexpressed Bcl-x L . Further evidence for the importance of Bcl-2 in regulating PDT-induced apoptosis has been obtained by reducing the level of Bcl-2 in cells through transfection of an antisense Bcl-2 sequence; the transfected cells were more sensitive to PDT (Zhang et al., 1999) . Because a variety of mechanisms has been proposed for the anti-apoptotic action of Bcl-2 (Gross et al., 1999; Kluck et al., 1997; Lam et al., 1994; Yang et al., 1997) , we sought to follow the fate of Bcl-2 itself following cell exposure to Pc 4-PDT.
In a study of human breast epithelial MCF-10A cells, Kim et al. (1999) found that in one clone overexpression of transfected Bcl-2 was accompanied by an upregulation of Bax. In contrast to expectations, the cells overexpressing Bcl-2 were more sensitive to the induction of apoptosis by PDT than were the parental cells. Interestingly, for both cell lines, the level of Bcl-2 detected on Western blots of the PDT-treated cells was much reduced in comparison to the untreated cells. The authors interpreted their results in terms of a possible PDT-mediated destruction of Bcl-2, thereby increasing the ratio of the pro-apoptotic Bax to antiapoptotic Bcl-2. In the present study, we show that the response of Bcl-2 to PDT is obtained in a variety of tumor and normal cell lines. Further, we provide evidence for possible mechanisms of the response.
Results
Loss of endogenous and overexpressed Bcl-2 in Pc 4-PDT-treated CHO cells.
In order to determine the response of Bcl-2 protein to Pc 4-PDT, cells of the 5A100-Bcl2 line were exposed to 500 nM Pc 4 and 10 kJ/m 2 of red light, and collected for assay at various times thereafter. Total cell protein was analysed by Western blot with an antibody directed against the transfected human Bcl-2 protein.
As shown in Figure 1A (left panel), immediately following Pc 4-PDT, there was a marked reduction in the amount of Bcl-2 detected on the blot. Although there appeared to be a slow partial recovery of the Bcl-2 level in the cells over a 2 h period after PDT, the control level was not restored in this time. Overexposure of the same blot revealed the presence of a trace amount of a 23-kDa fragment in the treated cells (see below). Because overexpressed human Bcl-2 may localize to dierent sites than the endogenous protein, in order to follow the fate of the endogenous hamster Bcl-2, 5A100 cells that had not received the human Bcl-2 cDNA were analysed similarly, using an antibody directed against mouse Bcl-2. The right panel of Figure  1a reveals that the endogenous Bcl-2 is also largely lost promptly after Pc 4-PDT. The PDT dose dependence of the Bcl-2 loss was investigated by exposing 5A100-Bcl2 cells to increasing¯uences of red light after uptake of a constant amount of Pc 4 (500 nM) and quantifying the intensity of the Bcl-2 band by densitometry. As revealed in Figure 1B , PDT doses that resulted in approximately 20, 50, 85 and 99% loss of clonogenicity, as determined earlier (He et al., 1996) , caused the loss of 32.5, 41.5, 45.5 and 72.0% of the Bcl-2, respectively. The loss of Bcl-2 was observed immediately after photoirradiation and for cells irradiated either at ambient temperature or after chilling them on ice ( Figure 1B ).
PDT-induced loss of Bcl-2 is a general phenomenon
To determine if the loss of Bcl-2 after exposure to Pc 4-PDT was a unique response of CHO cells or was a more general phenomenon, other cell lines have been studied. As shown in Figure 1C , the endogenous Bcl-2 protein of human prostate cancer LNCaP cells, and ) 5A100 and 5A100-Bcl2 cells at various times post-PDT. Anti-human and anti-mouse Bcl-2 antibodies were used for 5A100-Bcl2 and 5A100 cells, respectively. The same blot was exposed to ®lm for long (upper panel) or short (middle panel) periods. Actin was used for a loading control (bottom panel). (B) Dose-response for Bcl-2 loss in PDT-treated 5A100-Bcl2 cells. To quantify the results, the bands from this and another independent experiment were scanned by densitometry. The ratio of densities of each Bcl-2 band (upper panel) to its corresponding actin band (middle panel) was calculated, normalized to the control ratio, and the mean+standard deviation plotted (bottom panel; hatched bars). The per cent survival for each dose, as determined by clonogenic assay (He et al., 1996) is included for comparison (solid bars). *, Chilled cells (C) PDT-induced Bcl-2 loss in LNCaP, LNCaP-Etkwt and A431 cells. LNCaP cells were irradiated with 10 kJ/m 2 from the broadband light source. For A431 cells, 100 (*) or 200 (**) mJ/cm 2 were delivered by the LED array human epidermoid carcinoma A431 cells suers the same fate as the Bcl-2 protein of CHO cells. The same response was found for the endogenous Bcl-2 of LNCaP cells overexpressing the wild-type human Etk gene, which we have shown to protect cells from Pc 4-PDT-induced apoptosis ). These results demonstrate that Etk does not protect the cells against the initial photodamage.
Loss of Bcl-2 is independent of caspases and other proteases
Cells undergoing apoptosis in response to a variety of inducers, such as staurosporine, taxol, thiotepa, Fas ligand, VP-16, or IL3 withdrawal, generate a 23 kDa Bcl-2 cleavage product (Cheng et al., 1997; Fadeel et al., 1999; Fujita and Tsuruo, 1998; Grandgirard et al., 1998; Kirsch et al., 1999; Tudor et al., 2000) , and in several instances caspase-3 has been implicated as the responsible protease. In spite of the very rapid loss of Bcl-2 after Pc 4-PDT, the presence of a cleavage product ( Figure 1A ) of a similar size to that found in the earlier studies suggested that a protease could be responsible. To test the importance of caspase-3, the response of the endogenous Bcl-2 was followed in MCF-7v cells that have no procaspase-3 and MCF-7c3 cells that express transfected procaspase-3 (Janicke et al., 1998) . We con®rmed the procaspase-3-null status of MCF-7v cells and determined that the proenzyme of MCF-7c3 cells is activated to caspase-3 within 2 ± 4 h after Pc 4-PDT (Xue et al., 2001) . The data of Figure  2a demonstrate that the endogenous Bcl-2 protein of the two MCF-7 cell lines responded similarly to the treatment, and therefore, caspase-3 is not necessary for the prompt loss of Bcl-2 in Pc 4-PDT-treated cells. Furthermore, overexposure of the western blot of Bcl-2 protein in Figure 2B revealed that the 23 kDa Bcl-2 fragment was generated by PDT to similar levels immediately after photoirradiation at ambient temperature or in chilled cells, and the level did not change during a 60-min post-PDT incubation of the cells at 378C. Such data argue against proteolytic or other enzymatic activities as responsible factors either in the loss of Bcl-2 or in the formation of the fragment. The absence of any eect of several broad-spectrum protease inhibitors on the Pc 4-PDT-induced loss of Bcl-2 provides additional evidence that the observed eects on Bcl-2 are independent of most proteases ( Figure 2C ). The proteasome inhibitor MG-132 (He et al., 1998) also did not block the PDT-induced loss of Bcl-2 (data not shown).
Potential fates of Bcl-2 following PDT
Other candidate mechanisms that might account for the observed loss of Bcl-2 include phosphorylation or other modi®cation of the protein and direct photochemical damage. When the proteins were subjected to extended electrophoresis, it was observed ( Figure 3A ) that the main Bcl-2 band was trailed by a second more slowly migrating component that could represent a small amount of phosphorylated Bcl-2 (Haldar et al., 1996) . After PDT, when the majority of the main Bcl-2 band is lost, the Bcl-2 doublet is more apparent, suggesting that the non-phosphorylated Bcl-2 is preferentially lost. However, the combined amount of protein in the two bands accounts for only a tiny fraction of the total Bcl-2 present in the control sample. Thus, in spite of this indirect evidence for phosphorylation of Bcl-2, another mechanism must be responsible for the loss of the majority of the protein. Figure 3A also shows that neither staurosporine nor û-lapachone, both of which induce apoptosis (Jacobsen Bcl-2 cleavage in PDT-treated MCF-7v cells. Cells were treated as in a and collected at 0 or 60 min post-PDT. After ECL detection, the ®lm was exposed for long (upper panel) or short (middle panel) time. Where indicated by an asterisk (*), the cells were placed on ice for 10 min before light exposure. (C) The eects of various protease inhibitors on PDT-induced Bcl-2 loss in 5A100 ± Bcl2 cells. For PDT, cells were loaded with 500 nM Pc 4 for *18 h. One hour before irradiation (10 kJ/m 2 ), cells were transferred to fresh medium without (7) or with 50 mM zVAD (V), 20 mM TPCK (P), 20 mM TLCK (L), 10 mM E-64-d (E), or a protease inhibitor mixture (M) containing 2 mg/ml leupeptin, 2 mg/ml aprotinin, and 5 mg/ml antipain. Cells were collected 10 min after light exposure. Samples from cells untreated (c) or treated with light alone (hu), Pc 4 alone, or each inhibitor alone were also included Wuerzberger et al., 1998) , resulted in loss of Bcl-2. We know of no treatment of cells, other than PDT, that produces a similar eect on Bcl-2, i.e., immediate treatment-induced loss of the protein.
Another PDT-mediated modi®cation of Bcl-2 protein is revealed on overexposed western blots, on which signi®cant anti-Bcl-2-reactive material is found in a band at the approximate size of a Bcl-2 dimer (52 kDa) and in the high molecular weight region of the blot ( Figure 3B ). These observations suggest that a portion of the Bcl-2 molecules become crosslinked either to other Bcl-2 monomers or to other proteins. The chemical composition of the apparently crosslinked protein is under investigation.
Response of Bcl-2 to Pc 4-PDT: Protein loss or epitope destruction?
The results presented above, including the immediate loss of Bcl-2 and the inability of cold temperature or protease absence or inhibition to block the PDT eect, favor a photochemical mechanism for the loss of Bcl-2.
We next examined whether the inability to detect Bcl-2 from PDT-treated cells on the Western blots was due to photochemical damage to the epitope recognized by the Bcl-2 antibodies. If such were the case, it is possible that Bcl-2 protein may be present on the membrane but unable to react with the detecting antibodies. To test this possibility, we selected an epitope-tagged Bcl-2 that could be probed with antibodies to both Bcl-2 and the chimeric epitope, FLAG. For these experiments, we studied human prostate cancer DU145 cells, both parental cells and cells expressing FLAG-tagged Bcl-2. Both cell lines were exposed to increasing doses of Pc 4-PDT, and Western blots of their proteins were probed with both anti-human Bcl-2 and anti-FLAG antibodies. As shown in Figure 4 , the loss of anti-Bcl-2-reactive protein was observed in both cell lines in response to PDT, and loss of the FLAG-tagged protein could also be observed with anti-FLAG. These data suggest that the Bcl-2 protein is no longer present on the membrane at the position of the undamaged protein, or that photochemical damage to the protein extends to the FLAG epitope. The former explanation appears more likely in view of the data in Figure 3b .
Response of other mitochondrial and Bcl-2-related proteins to Pc 4-PDT Bcl-2 is located on the outer mitochondrial membrane as well as in the endoplasmic reticulum and the nuclear membrane (Reed et al., 1998) . Other members of the Bcl-2 family are also found in mitochondria either constitutively or in response to an apoptotic signal (Gross et al., 1999) . Therefore, we addressed the question of the protein speci®city of the response we have observed with Bcl-2. Figure 5 reveals that neither Bax nor Bad nor Bcl-x L respond to Pc 4-PDT as does Bcl-2; the level of these proteins remains as great in the treated as in the untreated cells. Furthermore, we previously observed no change in the level of cytochrome c, in spite of its release from the mitochondria into the cytosol, and no change in one Figure 4 The relative sensitivities of the anti-Bcl-2 and anti-FLAG epitopes of FLAG-tagged Bcl-2. DU145 and DU145-Bcl2 cells were exposed to PDT as indicated, cells were collected 10 min later, and western blots of their proteins were probed with anti-human Bcl-2 (top panel), anti-FLAG (middle panel), and anti-actin (bottom panel) Figure 1a was exposed to X-ray ®lm for a longer period of the peptides of cytochrome oxidase (Varnes et al., 1999) . Other mitochondrial proteins that have been studied are the voltage-dependent anion channel (VDAC1) and the adenine nucleotide translocator (ANT), proteins of the outer and inner mitochondrial membranes, respectively. Neither of these proteins was lost upon treatment with Pc 4-PDT. Thus, the photochemical damage to Bcl-2 is not a general response of mitochondrial proteins to PDT.
Prevention of Bcl-2 loss and apoptosis by L-histidine
In order to test the association of the photochemical damage to Bcl-2 and the subsequent apoptosis, histidine was used as a scavenger of singlet oxygen ( Figure 6 ). Histidine itself did not induce apoptosis in A431 cells and had no eect on the Bcl-2 level. However, under conditions in which nearly all Bcl-2 was photochemically damaged and 91.1+4.9% of the cells were apoptotic in 4 h, histidine protected against both responses. The Bcl-2 bands of Figure 6b and two similar experiments were scanned to reveal that PDT reduced the intensity to 11+4% (mean+s.d.) of the untreated control, whereas when L-histidine was present, the band intensity was reduced to 43+16% (mean+s.d.) of the control. The data suggest that Bcl-2 loss contributes to the subsequent entry of Pc 4-PDT-treated cells into apoptosis.
Discussion
The present study demonstrates that PDT causes a unique type of damage to the Bcl-2 protein that is not found in cells treated with other apoptosis-inducing agents, i.e., staurosporine or û-lapachone. Pc 4-PDT causes photochemical damage that dramatically diminishes the amount of intact Bcl-2 detectable by Western blot analysis. The only other reported instance of immediate loss of Bcl-2 also resulted from treatment of cells (MCF-10A human breast epithelial cells) with PDT photosensitized by aluminum phthalocyanine that also targets mitochondria (Kim et al., 1999) . All of the cell lines used by Kim et al. (1999) and in the present study are malignant cells, except the CHO and MCF-10A cells, which are also not normal after many years in culture. Therefore, it will be interesting to determine whether there is any dierential photodamage to normal vs malignant cells.
Bcl-2 cleavage into a 23-kDa fragment that can be pro-apoptotic has been observed as a late event in apoptosis in response to a variety of inducing agents, including Fas ligand, alphavirus, and several types of cancer chemotherapeutic agents (Gross et al., 1999) , but none of these produces a loss of Bcl-2 at early times in the apoptotic process. Bcl-2 phosphorylation has been observed in cells treated with the microtubule damaging drug taxol (Haldar et al., 1996) but is rarely found otherwise.
Several mechanisms have been proposed to explain the inhibition of apoptosis by Bcl-2, including participation by Bcl-2 in an anti-oxidant pathway (Hockenbery et al., 1993) , formation of an ion channel in membranes (Antonsson et al., 1997) , blockage of the release of cytochrome c (Gross et al., 1999; Reed et al., 1998; Yang et al., 1997) , and formation of dimers with pro-apoptotic Bcl-2 family members (Gross et al., 1999) . It has been reported that overexpressed Bcl-2 does not block the PDT-induced release of cytochrome c from mitochondria but rather inhibits subsequent steps in the caspase activation pathway (Carthy et al., 1999) . We have con®rmed this observation in Pc 4-PDT-treated CHO cells (Chiu et al., unpublished) . One explanation for the absence of a Bcl-2 inhibition of cytochrome c release when PDT is the initiating agent is that PDT may immediately destroy Bcl-2 in the most important sites regulating cytochrome c location. However, overexpressed Bcl-x L was also unable to block cytochrome c release (Carthy et al., 1999 ), yet in our experiments endogenous Bcl-x L protein was detected in control amounts among the proteins of PDT-treated cells ( Figure 5 ). The dierence between Bcl-2 and Bcl-x L in susceptibility to loss of protein in response to PDT may re¯ect their dierential location in the membranes or structural dierences between the proteins. Alternatively, photochemical damage to Bclx L may not crosslink it or otherwise change its ability to migrate as the native protein during electrophoresis. Furthermore, the ability of overexpressed Bcl-2 or Bclx L to block caspase activation even when it cannot block cytochrome c release following PDT may indicate that the Bcl-2 proteins prevent the release of other proteins, such as procaspase-9, from the mitochondria (Susin et al., 1999) .
It has been proposed that a major in¯uence over a cell's propensity to undergo apoptosis in response to a toxic stimulus is the ratio of Bax to Bcl-2 (Korsmeyer, 1999) . Bax appeared to be unaected by PDT; thus, elevated Bax may promote apoptosis even in the presence of Bcl-2 (Kim et al., 1999) . Since the level of Bax was the same in the two CHO cell lines used in the present study (data not shown), upregulation of Bax by Bcl-2 overexpression is not a general response. Thus, even after reduction of the Bcl-2 level by PDT, the Bax/Bcl-2 ratio may still be weighted toward increased resistance to Pc 4-PDT.
In spite of the formation of a small amount of the 23 kDa cleavage fragment in PDT-treated cells, it appears that the majority of the lost protein does not follow this pathway. Rather, the weight of evidence is in favor of a mechanism involving photochemical damage to Bcl-2. First, western blots of proteins from the treated cells but not from the control cells reveal multiple high-molecular weight bands recognized by the anti-Bcl-2 antibody, suggestive of the chemical crosslinking of Bcl-2 to itself or other proteins. Crosslinking of lamin B and the generation of high molecular weight slowly migrating protein bands has been observed in studies of the response of HL-60 cells to PDT photosensitized by hypericin or an anthraquinone (Lavie et al., 1999) . Second, protease inhibitors do not prevent the loss of Bcl-2 protein. And third, the reaction takes place immediately upon photoirradiation of Pc 4-loaded cells and in the cold.
The present studies do not reveal the sites or details of the photochemical damage to Bcl-2. It is generally assumed that the primary photochemical mechanism of PDT involves energy transfer from the triplet photosensitizer to ground state oxygen to generate the highly reactive singlet oxygen (Weishaupt et al., 1976) , and Pc 4 has been demonstrated to be a highly ecient generator of singlet oxygen (He et al., 1997) . Amino acids that are preferential targets of singlet oxygen are histidine, tryptophan, phenylalanine, tyrosine, methionine, and cysteine (Halliwell and Gutteridge, 1989) , and inspection of the amino acid sequence of Bcl-2 reveals many possibilities for photochemical reaction of these amino acid residues throughout the protein (Eguchi et al., 1992; Tsujimoto and Croce, 1986) .
The observation that histidine, a singlet oxygen scavenger, markedly protected A431 cells against both Bcl-2 loss and apoptosis suggests that the photochemical destruction of Bcl-2 is relevant to overall PDT response. However, the protection against apoptosis was greater than the protection against Bcl-2 loss, indicating that there is not a simple one-to-one correlation between these two events. Possible explanations are an action of histidine on steps in the apoptotic pathway in addition to singlet oxygen scavenging and an inability of partially protected mitochondrial Bcl-2 to fully prevent the initiation of apoptosis. Since Bcl-2 is immediately destroyed by PDT, the level of Bcl-2 in the cells prior to treatment should not protect them against PDT-induced cell death. However, cells overexpressing Bcl-2 are more resistant to the lethal eects of PDT He et al., 1996) , and downregulation of Bcl-2 with antisense oligonucleotides has been reported to sensitize cells to PDT (Zhang et al., 1999) . Either the photochemically damaged Bcl-2 is still able to exert some anti-apoptotic response or the small amount of residual undamaged Bcl-2 that remains in extramitochondrial compartments is able to protect them. Further research will be required to distinguish between these and other possibilities.
Materials and methods

Cell culture
The human breast cancer MCF-7 (WS8) cell line transfected with the pBabepuro retroviral vector encoding human CPP32 (procaspase-3) cDNA (here referred to as MCF-7c3 cells) or empty vector (MCF-7v) were provided by Dr CJ Froelich (Northwestern Univ., Evanston, IL, USA). Both cell lines were cultured in RPMI-1640 medium containing 10% fetal bovine serum (FBS) and 2 mg/ml of puromycin. Monolayer cultures of CHO cells (line 5A100 and 5A100-Bcl2) were maintained in McCoy's 5A medium containing 10% FBS. 5A100-Bcl2 overexpresses a human Bcl-2 gene (Bissonnette et al., 1992; He et al., 1996) . Human prostate LNCaP cells were grown in RPMI 1640 medium containing 10% FBS; a subline overexpressing Etk (LNCaP-Etkwt) was grown in the same medium with the addition of 500 mg/ml of G418 (Qiu et al., 1998; Xue et al., 1999) . Human epidermoid carcinoma A431 cells, human prostate cancer DU145 cells, and DU145 cells transfected with FLAG-Bcl-2 cDNA (DU145-Bcl2) were grown in DMEM medium containing 10% (A431 cells) or 5% (DU145 cells) FBS. All cultures were maintained in a humidi®ed atmosphere at 378C with 5% CO 2 .
Photodynamic treatment
The phthalocyanine photosensitizer Pc 4, HOSiPcOSi(CH 3 ) 2 (CH 2 ) 3 N(CH 3 ) 2 , was provided by Drs Ying-syi Li and Malcolm E Kenney, Case Western Reserve University Department of Chemistry (Oleinick et al., 1993) . It was dissolved in dimethyl formamide to 0.5 mM. Cells were loaded with Pc 4 by addition of an aliquot of the stock solution to the culture medium *18 h before irradiation. Inhibitors, when used, were added 1 h before irradiation. For all experiments, except those on CHO cells, the light source was an EFOS LED array (EFOS, Mississauga, ONT, Canada) delivering red light (lmax &675 nm; band width at half-maximum=24 nm;¯uence rate at the level of the cell monolayer 6 ± 7 mW/cm 2 ). In order to replicate the conditions of an earlier study (He et al., 1996) , CHO cells were irradiated using a 500-W tungsten-halogen lamp placed 29 inches below the surface of a glass exposure tray and ®ltered (600-nm long-pass ®lter). All irradiations were performed at room temperature except where indicated.
Antibodies and inhibitors
Monoclonal hamster anti-human Bcl-2 and anti-mouse Bcl-2 antibodies were from Pharmingen (San Diego, CA, USA). Other antibodies were obtained from the following companies: polyclonal anti-Bcl-x L , anti-Bax, anti-VDAC1, and anti-ANT from Santa Cruz (Santa Cruz, CA, USA); monoclonal anti-Bad from Transduction Laboratories (Lexington, KY, USA), anti-actin from Amersham (Arlington Heights, IL, USA), and anti-FLAG from Sigma (St. Louis, MO, USA).
zVAD-fmk and E-64-d were from BIOMOL (Plymouth Meeting, PA, USA), aprotinin and antipain from Roche (Indianapolis, IN, USA), and all other inhibitors from Sigma (St. Louis, MO, USA).
Western blot analysis
Cells were lysed and sonicated in a solution containing 0.5% sodium deoxycholate, 0.2% sodium dodecyl sulfate (SDS), 1% Triton X-100, 5 mM EDTA, 10 mg/mL leupeptin, 10 mg/ ml aprotinin, and 1 mM phenylmethanesulfonyl¯uoride in phosphate-buered saline. An equal volume of 26SDS sample buer (125 mM Tris, pH 6.8, 4% SDS, 10% mercaptoethanol, and 20% glycerol) was added to the cell lysate. Equivalent amounts of protein were loaded onto polyacrylamide gels, subjected to electrophoresis, transferred to a PVDF membrane and incubated with antibodies. The immune complexes were detected by ECL system (Amersham, Arlington Heights, IL, USA).
Nuclear staining assay for apoptotic cells
Apoptotic cells were identi®ed by¯uorescence microscopy from their characteristic nuclear features of chromatin condensation and fragmentation after staining cells with 5 mg/ml Hoechst 33342. At least 200 cells were counted from each sample, and the yield of apoptotic cells was expressed as the percentage of the total population.
